Cardiovascular Research

How to save a life during a clinic visit for erectile dysfunction by modifying cardiovascular risk factors.

Authors: B G Schwartz|||R A Kloner

Affiliations: + Expand

Abstract

Erectile dysfunction (ED) is an early marker for systemic atherosclerosis and is a predictor for coronary artery disease and cardiac events. The aim of this paper is to convey the importance of addressing cardiovascular risk factors in patients with ED and to inform urologists as well as other physicians who are not specialized in cardiology how to carry out a basic cardiovascular evaluation, including history, physical examination and objective data. We review the evidence and pathophysiology linking ED to cardiovascular disease, and then describe how to carry out a basic cardiovascular evaluation. We present data from the literature showing that appropriate use of lifestyle modifications and medical therapy has a positive effect on mortality, on numerous cardiovascular end points and on ED. Suggestions of when to refer the ED patient to an internist or cardiologist are provided. Identifying and treating cardiovascular risk factors may not only benefit the patient's ED, but it might also save the patient's life.

---

Reference List

Ann Intern Med. 2004 Sep 21;141(6):421-31|||Postgrad Med J. 2007 Nov;83(985):698-704|||Int J Impot Res. 2008 Dec;20 Suppl 2:S21-2|||Circulation. 2004 Jan 27;109(3):433-8|||Am J Hypertens. 1999 Mar;12(3):271-5|||Am J Med. 1988 Mar;84(3 Pt 1):445-8|||BMJ. 1999 Jan 16;318(7177):192|||Fertil Steril. 2007 Aug;88(2):369-73|||Circulation. 2004 Nov 9;110(19):3149-55|||JAMA. 2004 Jun 23;291(24):2978-84|||Int J Impot Res. 2009 May-Jun;21(3):192-7|||Am J Hypertens. 2001 Jan;14(1):27-31|||Mayo Clin Proc. 2009 Feb;84(2):108-13|||Int J Clin Pract. 2008 Jun;62(6):973-6|||JAMA. 2005 Dec 21;294(23):2996-3002|||J Urol. 2006 Sep;176(3):1081-5; discussion 1085|||Int J Impot Res. 2009 May-Jun;21(3):149-57|||Circulation. 2004 Jul 13;110(2):227-39|||Int J Impot Res. 2009 Jan-Feb;21(1):24-36|||J Androl. 2003 Nov-Dec;24(6 Suppl):S17-37|||Int J Clin Pract. 2006 Feb;60(2):141-5|||N Engl J Med. 2000 Jun 15;342(24):1802-13|||Urology. 2000 Aug 1;56(2):302-6|||Am Heart J. 1999 Oct;138(4 Pt 1):731-9|||Hypertension. 1988 Jul;12(1):1-10|||J Urol. 2004 Apr;171(4):1601-4|||N Engl J Med. 2008 Jun 12;358(24):2630-3|||J Urol. 2003 Aug;170(2 Pt 2):S46-50; discussion S50|||J Am Coll Cardiol. 2004 Jan 21;43(2):185-6|||Curr Treat Options Cardiovasc Med. 2006 Aug;8(4):276-81|||BMJ. 2009 May 19;338:b1665|||Lancet. 1992 Nov 7;340(8828):1111-5|||JAMA. 2002 Dec 18;288(23):2981-97|||J Urol. 1994 Jan;151(1):54-61|||N Engl J Med. 2008 Jun 12;358(24):2545-59|||J Urol. 2004 Jul;172(1):255-8|||Int J Impot Res. 2004 Aug;16(4):350-3|||Urol Clin North Am. 2005 Nov;32(4):397-402, v|||Eur J Pharmacol. 2004 Sep 13;498(1-3):189-94|||Int J Impot Res. 2008 Dec;20 Suppl 2:S9-14|||Int J Impot Res. 2009 Mar-Apr;21(2):116-21|||Circulation. 2006 May 16;113(19):2363-72|||Diabetologia. 2001 Sep;44(9):1155-60|||Am J Med. 2000 Jul;109(1):59-61|||Health Technol Assess. 2003;7(31):1-94|||Am J Public Health. 1990 Aug;80(8):954-8|||JAMA. 2005 Nov 23;294(20):2623-9|||Am Fam Physician. 1998 Oct 15;58(6):1355-62, 1369-70|||Circulation. 2004 Jul 6;110(1):22-6|||Int J Impot Res. 2009 May-Jun;21(3):179-86|||N Engl J Med. 2008 Oct 9;359(15):1577-89|||Br Heart J. 1991 Mar;65(3):116-25|||Int J Impot Res. 2008 Dec;20 Suppl 2:S2-8|||Eur Urol. 2005 Dec;48(6):996-1002; discussion 1002-3|||N Engl J Med. 1986 Feb 20;314(8):488-500|||Urol Clin North Am. 2007 Nov;34(4):463-82, v|||J Am Coll Cardiol. 2004 Jan 21;43(2):179-84|||Lancet. 2003 Nov 8;362(9395):1527-35|||Eur Urol. 2003 Sep;44(3):352-4|||Fam Pract. 2002 Feb;19(1):95-8